A- A A+

Tablettenschmuggel für den großen Bruder - Der Fall Claudia J. (Video)

Stell dir vor, dein Bruder braucht dringend deine Hilfe. Dafür müsstest du das Gesetz brechen. Wie weit würdest du gehen? 

Claudia Jaworski hat Betäubungsmittel ins Gefängnis geschmuggelt, für ihren großen Bruder. Er ist seit vielen Jahren heroinabhängig. Um mit der Sucht besser leben zu können, nimmt er Ersatzdrogen. 

Doch in der JVA Bernau bekommt er keine Substitutionstherapie. (Der Fall (ZDF/ARD), 11.01.2022, Video, 09:37)


Trends in Buprenorphine Use in US Jails and Prisons From 2016 to 2021. 

Thakrar AP, Alexander GC, Saloner B. 

JAMA Netw Open. 2021 Dec 1;4(12):e2138807. doi: 10.1001/jamanetworkopen.2021.38807. PMID: 34905010; PMCID: PMC8672225.


Rates of opioid agonist treatment prescribing in provincial prisons in Ontario, Canada, 2015-2018: a repeated cross-sectional analysis. 

Bodkin C, Bondy S, Regenstreif L, Kiefer L, Kouyoumdjian F. 

BMJ Open. 2021 Nov 18;11(11):e048944. doi: 10.1136/bmjopen-2021-048944. PMID: 34794988; PMCID: PMC8603292.


A qualitative study of diphenhydramine injection in Kyrgyz prisons and implications for harm reduction. 

Meyer JP, Culbert GJ, Azbel L, Bachireddy C, Kurmanalieva A, Rhodes T, Altice FL. 

Harm Reduct J. 2020 Oct 31;17(1):86. doi: 10.1186/s12954-020-00435-7. PMID: 33129341; PMCID: PMC7603760.


Fifteen years of heroin-assisted treatment in a Swiss prison-a retrospective cohort study. 

Liebrenz M, Gamma A, Buadze A, Schleifer R, Baggio S, Schwartz B, Schneeberger A, Uchtenhagen A. 

Harm Reduct J. 2020 Oct 13;17(1):67. doi: 10.1186/s12954-020-00412-0. PMID: 33046103; PMCID: PMC7552491.


UK. Lifesaving antidote to be given to drug users as they leave custody

West Midlands Police has begun offering people with Class A drug addictions a lifesaving overdose antidote as they are released from custody as part of our wider harm reduction strategy.

The scheme, which is funded by the Police and Crime Commissioner Simon Foster, will hand drug users a medicine called Naloxone, which can reverse the effects of an overdose. (west midlands police and crime commissioner, UK, 03.11.2021)


Baden-Württemberg. JUSTIZVOLLZUG. Expertenkommission übergibt Medizinkonzept für Justizvollzug

Die Expertenkommission zur medizinischen Versorgung im baden-württembergischen Justizvollzug hat Justizminister Guido Wolf ihren Abschlussbericht übergeben. Im Bericht sind 30 konkrete Empfehlungen zur Weiterentwicklung der medizinischen Versorgung der Gefangenen angeführt. (Staatsministerium Baden-Württemberg, 19.3.2021)


USA/NY. Hochul signs bills to address growing overdose crisis, expand treatment into jails, prisons

Advocates press governor to take further steps that reduce harm amid record overdose rates. (Times Union, USA, 07.10.2021)


Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail. 

Lee JD, Malone M, McDonald R, Cheng A, Vasudevan K, Tofighi B, Garment A, Porter B, Goldfeld KS, Matteo M, Mangat J, Katyal M, Giftos J, MacDonald R. 

JAMA Netw Open. 2021 Sep 1;4(9):e2123032. doi: 10.1001/jamanetworkopen.2021.23032. PMID: 34495340; PMCID: PMC8427378.


Fatal overdoses after release from prison in British Columbia: a retrospective data linkage study. 

Kinner SA, Gan W, Slaunwhite A. 

CMAJ Open. 2021 Sep 28;9(3):E907-E914. doi: 10.9778/cmajo.20200243. PMID: 34584005; PMCID: PMC8486467.


Evaluation of a national smoke-free prisons policy using medication dispensing: an interrupted time-series analysis

Tweed, Emily J et al.

The Lancet Public Health, Volume 0, Issue 0 


The impact of the COVID-19 lockdown on drug service provision in European prisons. 

Montanari L, Teltzrow R, Vanmalderen S, Ranieri R, Martín Peláez JA, Vandam L, Mounteney J, Pirona A, Meroueh F, Giraudon I, Matias J, Skarupova K, Royuela L, Morel d'Arleux J. 

Int J Prison Health. 2021 Aug 21;ahead-of-print(ahead-of-print). doi: 10.1108/IJPH-11-2020-0089. PMID: 34410050.


USA. Judge Rules in Favor of New York Prisoner Suing for Methadone Access

A District Court judge has issued a preliminary injunction to ensure that a 35-year-old Watertown, New York, resident can continue accessing his medication for opioid use disorder (MOUD) while detained in Jefferson County Jail. It’s the first such ruling in the Second Circuit, the Court of Appeals that includes New York state. (Filter, USA, 13.09.2021)


Strategies to maximise study retention and limit attrition bias in a prospective cohort study of men reporting a history of injecting drug use released from prison: the prison and transition health study. 

Stewart, A.C., Cossar, R., Walker, S. et al.

BMC Med Res Methodol 21, 185 (2021). doi.org/10.1186/s12874-021-01380-0


Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail. 

Lee JD, Malone M, McDonald R, et al. 

JAMA Netw Open. 2021;4(9):e2123032. doi:10.1001/jamanetworkopen.2021.23032


National Snapshot: Access to Medications for Opioid Use Disorder in U.S. Jails and Prisons

Shelly Weizman Taleed El-Sabawi Joanna Perez Melissa Baney Isaac Manoff 

O'Neill Institute, USA, July 28, 2021

THIS 50 STATE SNAPSHOT presents current laws, policies, and court actions related to access to medications for opioid use disorder (MOUD) in correctional facilities in the U.S as of April 2021. Where available, this survey also includes examples of programs that are county- or facility-specific.


The impact of the opioid crisis on U.S. state prison systems. 

Scott CK, Dennis ML, Grella CE, Mischel AF, Carnevale J. 

Health Justice. 2021 Jul 24;9(1):17. doi: 10.1186/s40352-021-00143-9. PMID: 34304335; PMCID: PMC8310396.


Coronavirus (COVID-19) opioid substitution treatment in prisons - evaluation: patient experience follow-up report

Follow up report on opiate substitution therapy (OST) in Scotland’s prison during COVID-19. This report explores the experiences of patients living in prisons changing their OST prescription to Buvidal.

Scottish Government, Population Health Directorate. 07.07.2021, ISBN:



Factors Associated with Incarceration in Older Adults Experiencing Homelessness: Results from the HOPE HOME Study. 

Garcia-Grossman I, Kaplan L, Valle K, Guzman D, Williams B, Kushel M. 

J Gen Intern Med. 2021 Jun 9:1–9. doi: 10.1007/s11606-021-06897-0. Epub ahead of print. PMID: 34109543; PMCID: PMC8189551.


What are the greatest health challenges facing people who are incarcerated? We need to ask them 

Published online: June 8, 2021 

Justin Berk, Josiah D Rich, Lauren Brinkley-Rubinstein 

The Lancet Public Health 


The Harms of Incarceration: The evidence base and human rights framework for decarceration and harm reduction in prisons

This briefing provides advocates with the evidence base and human rights framework for decarceration and the provision of harm reduction services in prisons. (hri – Harm Reduction International, UK, 2021)


Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings, 

Dunlop, A. J., White, B., Roberts, J., Cretikos, M., Attalla, D., Ling, R., Searles, A., Mackson, J., Doyle, M. F., McEntyre, E., Attia, J., Oldmeadow, C., Howard, M. V., Murrell, T., Haber, P. S., and Lintzeris, N. (2021) 

Addiction. doi.org/10.1111/add.15627.


Baden-Württemberg. Ministerium der Justiz und für Europa: Medizinische Versorgung im baden-württembergischen Justizvollzug: Abschlussbericht der Expertenkommission (PDF)



Baden-Württemberg. Expertenkommission übergibt Medizinkonzept für Justizvollzug

Die Expertenkommission zur medizinischen Versorgung im baden-württembergischen Justizvollzug hat Justizminister Guido Wolf ihren Abschlussbericht übergeben. Im Bericht sind 30 konkrete Empfehlungen zur Weiterentwicklung der medizinischen Versorgung der Gefangenen angeführt. (Staatsministerium Baden-Württemberg, 19.03.2021)


Assessing factors associated with discharge from opioid agonist therapy due to incarceration in the United States. 

Marotta PL, Stringer KL, Mandavia AD, Davis A, Beletsky L, Hunt T, Goddard-Eckrich D, Wu E, Gilbert L, El-Bassel N. 

J Addict Dis. 2020 Jan-Mar;38(1):1-18. doi: 10.1080/10550887.2019.1690365. Epub 2019 Dec 10. PMID: 31821129; PMCID: PMC7224404.


Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder. 

Chappuy M, Meroueh F, Trojak B, Bachellier J, Bendimerad P, Kosim M, Hjelmström P, Nubukpo P, Brousse G, Rolland B. 

Patient Prefer Adherence. 2021 Jun 14;15:1259-1267. doi: 10.2147/PPA.S311674. PMID: 34163143; PMCID: PMC8214559.


The state of harm reduction in prisons in 30 European countries with a focus on people who inject drugs and infectious diseases. 

Stöver, H., Tarján, A., Horváth, G. et al.

Harm Reduct J 18, 67 (2021). doi.org/10.1186/s12954-021-00506-3


EMCDDA. Prison and drugs in Europe: current and future challenges


This publication provides an overview of current knowledge and the latest developments in the field of drug use and prison in Europe. The report explores in depth the epidemiology of drug use and drug-related problems among the prison population, the available social and health service responses to drug-related problems in prison, including the most recent evidence of effectiveness, and the drug supply and markets inside prison. It also discusses recent and future challenges in this area. The report will be of interest to policymakers and their advisors, specialists and practitioners, researchers and scientists and all those concerned with the issue of prison and drugs. (EMCDDA, Lissabon, Juni 2021)


New EMCDDA report underlines need to scale up drug services in prisons

Current insights and future challenges on drugs and prison in Europe are explored today in a major new study published by the EU drugs agency (EMCDDA)(1). Released on the eve of International day against drug abuse and illicit trafficking, the report, Prison and drugs in Europe: current and future challenges, takes an in-depth look at a wide range of issues in the prison setting, including drug use and harms, health and social responses and drug supply. It notes that, while, in several European countries, services in prison for people with drug problems have increased, treatment and care options available to this group remain limited and need to be scaled up. (EMCDDA, Lissabon, 25.06.2021, News release No 8/2021)


Bayern. Interview: „Letztlich empfahl der Anstaltsarzt meinem Bruder, sich im Hof Drogen zu besorgen“

Claudia Jaworski hat ihrem heroinabhängigen Bruder Substitutionsmittel ins Gefängnis gebracht, weil ihm in Haft die Behandlung verweigert wurde – und steht nun selbst vor Gericht. Aus einer besorgten Schwester wurde eine Aktivistin. (Deutsche AIDS-Hilfe, hiv-magazin, 14.06.2021)